New hope for kaposi sarcoma: pomalidomide shows promise in shrinking tumors
NCT ID NCT04577755
First seen Sep 30, 2025 · Last updated May 17, 2026 · Updated 25 times
Summary
This study tests a drug called pomalidomide in 45 people with Kaposi sarcoma, a type of skin cancer. The drug works by cutting off the tumor's blood supply and boosting the immune system to kill cancer cells. The goal is to see how long the tumors shrink and how many people respond to treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SKIN KAPOSI SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Johns Hopkins University/Sidney Kimmel Cancer Center
Baltimore, Maryland, 21287, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Miami Cancer Institute
Miami, Florida, 33176, United States
-
Montefiore Medical Center-Einstein Campus
The Bronx, New York, 10461, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
NYP/Weill Cornell Medical Center
New York, New York, 10065, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Pennsylvania Hospital
Philadelphia, Pennsylvania, 19107, United States
-
Thomas Street at Quentin Mease Health Center
Houston, Texas, 77004, United States
-
UC San Diego Moores Cancer Center
La Jolla, California, 92093, United States
-
University of Illinois
Chicago, Illinois, 60612, United States
-
University of Pennsylvania/Abramson Cancer Center
Philadelphia, Pennsylvania, 19104, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.